2012-01-17
December 2012, Biokvant Ltd. has received a EU Declaration of Conformity for its product – the hardware and software complex VedaPulse. The EU Declaration of Conformity is required for an export to the European Union. This document confirms the product compliance with the EU safety. Biokvant Ltd. officially declares by the issuance of the EC declaration of conformity that the VedaPulse HSC meets safety requirements for a medical equipment by European standards and Directives of the European Parliament and the Council.
<--- Previous article
The English version of the VedaPulse digital pulse diagnosis was presented in Beirut
Next article --->
VedaPulse has been approved for use in the Kingdom of Saudi Arabia